Skora Healthcare Private Limited
Isotretinoin (20mg)
Isoskora Capsule is a retinoid (vitamin A derivative) used to treat severe acne that has not responded to other treatments.
Capsule
Isoskora Capsule should be used in the dose and duration as advised by your doctor. Take it with food, preferably at the same time each day to avoid a missed dose. It may take several weeks for your symptoms to improve but keep taking the medicine regularly to get the most benefit. If you notice no improvement after a few weeks, see your doctor again.
Take this medicine in the dose and duration as advised by your doctor. Isoskora Capsule is to be taken with food.
Isoskora Capsule is a derivative of vitamin A. It acts on glands (sebaceous) to reduce the production of a natural substance (sebum) that causes acne..The controlled sebum production kills acne-causing bacteria..It also works as an anti-inflammatory to decrease inflammation (redness and swelling).
You have been prescribed Isoskora Capsule for the treatment of severe acne. Take it with food. Avoid exposure to sunlight while using Isoskora Capsule. Use protective measures such as sunscreen or protective clothing. Avoid face waxing and laser treatment while using this medicine as it makes your skin more fragile. It may cause dryness of mouth, lips, and eyes. Drink plenty of water, use moisturiser, and avoid wearing contact lenses. Inform your doctor if it bothers you.
Isoskora Capsule should be used with caution as it can cause serious adverse reactions. It is intended for patients experiencing severe nodular acne who have not responded to standard treatment, including systemic antibiotics. Additionally, pregnant women should avoid using Isoskora Capsule because it may result in severe birth defects.
No, Isoskora Capsule is a retinoid (vitamin A) medication used to treat severe acne.
Before starting treatment with Isoskora Capsule, your liver enzyme and serum lipid levels will be assessed. These levels will also be monitored monthly at first, then every three months unless indicated for more frequent monitoring by the physician.
Many patients experience a lasting improvement in their condition after completing a 15-20 week course of Isoskora Capsule. In most cases, this treatment effectively cures severe acne and prevents its recurrence. However, if a second course is necessary, it should be started at least eight weeks after the completion of the first one.
Isoskora Capsule use during pregnancy poses a high risk of serious birth defects in the baby. This is due to its potential for severe adverse effects on fetal development.
There's no evidence indicating that Isoskora Capsule causes cancer. It has actually been shown to be potentially beneficial in certain types of head, skin, and neck cancers.
A standard course of treatment for Isoskora Capsule is 15–20 weeks. Long-term effects related to low dose usage have not been extensively studied, however, it may potentially impact bone mineral density in some patients.
Isoskora Capsule has no known effect on the fertility of male patients. No significant changes were observed on ejaculate volume, sperm count, total sperm motility, morphology, or seminal plasma fructose.
There may be a transient increase in liver enzymes associated with Isoskora Capsule use. Therefore, regular laboratory tests are crucial to monitor. This increase generally resolves over time. If the values remain elevated for an extended period, your physician may discontinue Isoskora Capsule.